Duchenne Muscular Dystrophy Therapeutics Market - Global Outlook and Forecast 2021-2027

Code: RW00014576681
Market Monitor Global
Oct-2021
Life Sciences
93 Pages

This report contains market size and forecasts of Duchenne Muscular Dystrophy Therapeutics in Global, including the following market information:
Global Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Duchenne Muscular Dystrophy Therapeutics market was valued at 989.7 million in 2020 and is projected to reach US$ 2629.3 million by 2027, at a CAGR of 27.7% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Duchenne Muscular Dystrophy Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Duchenne Muscular Dystrophy Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Duchenne Muscular Dystrophy Therapeutics Market Segment Percentages, By Type, 2020 (%)
Pain Management Drugs
Corticosteroids
Prednisolone
Prednisone
Deflazacort

China Duchenne Muscular Dystrophy Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Duchenne Muscular Dystrophy Therapeutics Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics
Home Care

Global Duchenne Muscular Dystrophy Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Duchenne Muscular Dystrophy Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Duchenne Muscular Dystrophy Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Duchenne Muscular Dystrophy Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Bristol-Myers Squibb
FibroGen (US)
Italfarmaco (Italy)
Marathon
NS Pharma (US)
PTC Therapeutics (US)
Pfizer
ReveraGen BioPharma (US)
Santhera Pharmaceuticals (Switzerland)
Sarepta Therapeutics (US)

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Duchenne Muscular Dystrophy Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Duchenne Muscular Dystrophy Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Duchenne Muscular Dystrophy Therapeutics Overall Market Size
2.1 Global Duchenne Muscular Dystrophy Therapeutics Market Size: 2021 VS 2027
2.2 Global Duchenne Muscular Dystrophy Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Duchenne Muscular Dystrophy Therapeutics Players in Global Market
3.2 Top Global Duchenne Muscular Dystrophy Therapeutics Companies Ranked by Revenue
3.3 Global Duchenne Muscular Dystrophy Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Duchenne Muscular Dystrophy Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Duchenne Muscular Dystrophy Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Duchenne Muscular Dystrophy Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Duchenne Muscular Dystrophy Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Duchenne Muscular Dystrophy Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Duchenne Muscular Dystrophy Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Pain Management Drugs
4.1.3 Corticosteroids
4.1.4 Prednisolone
4.1.5 Prednisone
4.1.6 Deflazacort
4.2 By Type - Global Duchenne Muscular Dystrophy Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Duchenne Muscular Dystrophy Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Duchenne Muscular Dystrophy Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Duchenne Muscular Dystrophy Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Duchenne Muscular Dystrophy Therapeutics Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Home Care
5.2 By Application - Global Duchenne Muscular Dystrophy Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Duchenne Muscular Dystrophy Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Duchenne Muscular Dystrophy Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Duchenne Muscular Dystrophy Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Duchenne Muscular Dystrophy Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Duchenne Muscular Dystrophy Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Duchenne Muscular Dystrophy Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Duchenne Muscular Dystrophy Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Duchenne Muscular Dystrophy Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Duchenne Muscular Dystrophy Therapeutics Revenue, 2016-2027
6.3.2 US Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.3.3 Canada Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.3.4 Mexico Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Duchenne Muscular Dystrophy Therapeutics Revenue, 2016-2027
6.4.2 Germany Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.4.3 France Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.4.4 U.K. Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.4.5 Italy Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.4.6 Russia Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.4.8 Benelux Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Duchenne Muscular Dystrophy Therapeutics Revenue, 2016-2027
6.5.2 China Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.5.3 Japan Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.5.4 South Korea Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.5.6 India Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Duchenne Muscular Dystrophy Therapeutics Revenue, 2016-2027
6.6.2 Brazil Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.6.3 Argentina Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Duchenne Muscular Dystrophy Therapeutics Revenue, 2016-2027
6.7.2 Turkey Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.7.3 Israel Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
6.7.5 UAE Duchenne Muscular Dystrophy Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Corporate Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Duchenne Muscular Dystrophy Therapeutics Major Product Offerings
7.1.4 Bristol-Myers Squibb Duchenne Muscular Dystrophy Therapeutics Revenue in Global (2016-2021)
7.1.5 Bristol-Myers Squibb Key News
7.2 FibroGen (US)
7.2.1 FibroGen (US) Corporate Summary
7.2.2 FibroGen (US) Business Overview
7.2.3 FibroGen (US) Duchenne Muscular Dystrophy Therapeutics Major Product Offerings
7.2.4 FibroGen (US) Duchenne Muscular Dystrophy Therapeutics Revenue in Global (2016-2021)
7.2.5 FibroGen (US) Key News
7.3 Italfarmaco (Italy)
7.3.1 Italfarmaco (Italy) Corporate Summary
7.3.2 Italfarmaco (Italy) Business Overview
7.3.3 Italfarmaco (Italy) Duchenne Muscular Dystrophy Therapeutics Major Product Offerings
7.3.4 Italfarmaco (Italy) Duchenne Muscular Dystrophy Therapeutics Revenue in Global (2016-2021)
7.3.5 Italfarmaco (Italy) Key News
7.4 Marathon
7.4.1 Marathon Corporate Summary
7.4.2 Marathon Business Overview
7.4.3 Marathon Duchenne Muscular Dystrophy Therapeutics Major Product Offerings
7.4.4 Marathon Duchenne Muscular Dystrophy Therapeutics Revenue in Global (2016-2021)
7.4.5 Marathon Key News
7.5 NS Pharma (US)
7.5.1 NS Pharma (US) Corporate Summary
7.5.2 NS Pharma (US) Business Overview
7.5.3 NS Pharma (US) Duchenne Muscular Dystrophy Therapeutics Major Product Offerings
7.5.4 NS Pharma (US) Duchenne Muscular Dystrophy Therapeutics Revenue in Global (2016-2021)
7.5.5 NS Pharma (US) Key News
7.6 PTC Therapeutics (US)
7.6.1 PTC Therapeutics (US) Corporate Summary
7.6.2 PTC Therapeutics (US) Business Overview
7.6.3 PTC Therapeutics (US) Duchenne Muscular Dystrophy Therapeutics Major Product Offerings
7.6.4 PTC Therapeutics (US) Duchenne Muscular Dystrophy Therapeutics Revenue in Global (2016-2021)
7.6.5 PTC Therapeutics (US) Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Duchenne Muscular Dystrophy Therapeutics Major Product Offerings
7.4.4 Pfizer Duchenne Muscular Dystrophy Therapeutics Revenue in Global (2016-2021)
7.7.5 Pfizer Key News
7.8 ReveraGen BioPharma (US)
7.8.1 ReveraGen BioPharma (US) Corporate Summary
7.8.2 ReveraGen BioPharma (US) Business Overview
7.8.3 ReveraGen BioPharma (US) Duchenne Muscular Dystrophy Therapeutics Major Product Offerings
7.8.4 ReveraGen BioPharma (US) Duchenne Muscular Dystrophy Therapeutics Revenue in Global (2016-2021)
7.8.5 ReveraGen BioPharma (US) Key News
7.9 Santhera Pharmaceuticals (Switzerland)
7.9.1 Santhera Pharmaceuticals (Switzerland) Corporate Summary
7.9.2 Santhera Pharmaceuticals (Switzerland) Business Overview
7.9.3 Santhera Pharmaceuticals (Switzerland) Duchenne Muscular Dystrophy Therapeutics Major Product Offerings
7.9.4 Santhera Pharmaceuticals (Switzerland) Duchenne Muscular Dystrophy Therapeutics Revenue in Global (2016-2021)
7.9.5 Santhera Pharmaceuticals (Switzerland) Key News
7.10 Sarepta Therapeutics (US)
7.10.1 Sarepta Therapeutics (US) Corporate Summary
7.10.2 Sarepta Therapeutics (US) Business Overview
7.10.3 Sarepta Therapeutics (US) Duchenne Muscular Dystrophy Therapeutics Major Product Offerings
7.10.4 Sarepta Therapeutics (US) Duchenne Muscular Dystrophy Therapeutics Revenue in Global (2016-2021)
7.10.5 Sarepta Therapeutics (US) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Duchenne Muscular Dystrophy Therapeutics Market Opportunities & Trends in Global Market
Table 2. Duchenne Muscular Dystrophy Therapeutics Market Drivers in Global Market
Table 3. Duchenne Muscular Dystrophy Therapeutics Market Restraints in Global Market
Table 4. Key Players of Duchenne Muscular Dystrophy Therapeutics in Global Market
Table 5. Top Duchenne Muscular Dystrophy Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Duchenne Muscular Dystrophy Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Duchenne Muscular Dystrophy Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Duchenne Muscular Dystrophy Therapeutics Product Type
Table 9. List of Global Tier 1 Duchenne Muscular Dystrophy Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Duchenne Muscular Dystrophy Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE